Quantum量子訊息有限公司
← 最新全球產業報告

Asia Pacific Newborn Screening Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-02-19 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 299.9 Mn
2033 年預估規模
USD 631.5 Mn
年複合成長率 CAGR
9.2%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-02-19頁數 152報告編號 CMI2546

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Asia Pacific Newborn Screening Market, By Products Type (Hearing Screening Devices, Mass Spectrometer, Pulse Oximetry, and Assay Kits and Reagents), By Test Type (Phenylketonuria (PKU), Critical Congenital Heart Defect (CCHD), Hearing Screening, Sickle Cell Disease, Maple Syrup Urine Disease (MSUD), Thyroid Disorder, Biotinidase Deficiency (BTD), and Others), By End User (Hospitals, Maternity & Specialty Clinics, and Diagnostic Centers), By Geography (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific)

報告摘要

Newborn screening is a preventative public health initiative which allows detection of disorders early in life before clinical features are present. New-born screening allows these conditions to be detected at birth, allowing the child to potentially lead a normal and healthy life. The test simply requires a few drops of blood, which is collected on a special filter paper by pricking the heel of the baby. Newborn Screening is a comprehensive screening test done for your baby to detect the presence of medical conditions that can be hidden at birth. “Identify the conditions that could be harmful to your baby's growth with Neonatal screening.” Babies need screening during the first few days of life, because some of the conditions found by screening require treatment or intervention right away. NBS happens after birth, usually when your baby is between 24 and 48 hours (1 and 2 days) old. If a baby is tested before 24 hours, they may need to be retested. Screenings are done using the following methods: • Blood tests. A few drops of blood are taken from the baby's heel. The blood is sent to a lab for analysis. • Hearing test. A health care provider will place a tiny earpiece or microphone in the infant's ear. Another method uses electrodes that are put on the baby's head while the baby is quiet or asleep. • CCHD screen. A provider will place a small soft sensor on the baby's skin and attach it to a machine called an oximeter for a few minutes. The oximeter will measure the baby's oxygen levels in the hand and foot. Market Dynamics Demand for newborn screening is increasing in order to tackle various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million infants are unvaccinated resulting in death of 2-3 million children every year. Furthermore, PerkinElmer, Inc., a global corporation focused in the business areas of diagnostics, life science research, in January 2018, announced that it received market authorization from the China Food and Drug Administration (CFDA) to offer its Genetic Screening Processor (GSP) instrument and GSP Neonatal hTSH reagent kit. The GSP instrument is capable of testing for a wide range of disorders using PerkinElmer's dried blood spot assays on a single platform. The GSP is a fully automated, high throughput analyzer that tests neonatal dried blood spot samples to detect potentially life-threatening conditions in newborn babies. The GSP Neonatal hTSH reagent kit aids specifically in the detection of congenital hypothyroidism. Key features of the study • This report provides an in-depth analysis of the Asia pacific newborn screening market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the Asia pacific newborn screening market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Medtronic plc, Agilent Technologies, Waters Technologies Corporation, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare Pvt. Ltd., and ZenTech S.A. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The Asia pacific newborn screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Asia pacific newborn screening market Market Segmentation • By Products Type o Hearing Screening Devices o Mass Spectrometer o Pulse Oximetry o Assay Kits and Reagents • By Test Type o Phenylketonuria (PKU) o Critical Congenital Heart Defect (CCHD) o Hearing Screening o Sickle Cell Disease o Maple Syrup Urine Disease (MSUD) o Thyroid Disorder o Biotinidase Deficiency (BTD) o Others • By End User o Hospitals o Maternity & Specialty Clinics o Diagnostic Centers • By Country Insights o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific • Key Players Insights o Medtronic plc o Agilent Technologies o Waters Technologies Corporation o AB SCIEX o Bio-Rad Laboratories o Covidien PLC o GE Life Sciences o Masimo Corporation o Natus Medical Inc. o PerkinElmer Inc. o Trivitron Healthcare Pvt. Ltd. o ZenTech S.A.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By Test Type  Market Snapshot, By End User  Market Snapshot, By Countries o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Merger and Acquisition o Technology Advancements o Product Launches o Government Initiatives o Epidemiology o Product Recalls o Regulatory Scenario o PORTER’S Five Forces o PEST Analysis 4. Asia Pacific Newborn Screening Market, By Product Type, 2026- 2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2026- 2033  Segment Trends o Hearing Screening Devices  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Mass Spectrometer  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Pulse Oximetry  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Assay Kits and Reagents  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Asia Pacific Newborn Screening Market, By Test Type, 2026- 2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2026- 2033  Segment Trends o Phenylketonuria (PKU)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Critical Congenital Heart Defect (CCHD)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Hearing Screening  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Sickle Cell Disease  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Maple Syrup Urine Disease (MSUD)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Thyroid Disorder  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Biotinidase Deficiency (BTD)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Asia Pacific Newborn Screening Market, By End User, 2026- 2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2026- 2033  Segment Trends o Hospitals  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Maternity & Specialty Clinics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Diagnostic Centers  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Asia Pacific Newborn Screening Market, By Countries, 2026- 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2021-2033  Regional Trends o China  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026- 2033, (USD Mn) o India  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026- 2033, (USD Mn) o Japan  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026- 2033, (USD Mn) o Australia  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026- 2033, (USD Mn) o South Korea  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026- 2033, (USD Mn) o ASEAN  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026- 2033, (USD Mn) o Rest of Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026- 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2026- 2033, (USD Mn) 8. Competitive Landscape o Heat Map Analysis o Company Profiles  Medtronic plc o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Bio-rad Laboratories, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  GE Healthcare o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  PerkinElmer, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Waters Technologies Corporation o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Masimo Corporation o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Natus Medical Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Trivitron Healthcare Pvt. Ltd. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  ZenTech S.A. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Agilent Technologies, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies  Danaher Corporation (AB SCIEX) o Company Overview o Product Portfolio o Financial Performance o Recent Highlights o Strategies o Analyst Views 9. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Medtronic plcAgilent TechnologiesWaters Technologies CorporationAB SCIEXBio-Rad LaboratoriesCovidien PLCGE Life SciencesMasimo CorporationNatus Medical Inc.PerkinElmer Inc.Trivitron Healthcare Pvt. Ltd.ZenTech S.A.

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們